Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis C in India.

Literature DB >> 19208972

Hepatitis C in India.

Abstract

Hepatitis C is an emerging infection in India and an important pathogen causing liver disease in India.The high risk of chronicity of this blood-borne infection and its association with hepatocellular carcinoma underscores its public health importance. Blood transfusion and unsafe therapeutic interventions by infected needles are two preventable modalities of spread of hepatitis C infection. In addition, risk factor modification by reducing the number of intravenous drug users will help curtail the prevalence of this infection. This review summarizes the extent, nature and implications of this relatively new pathogen in causing disease in India.

Entities: Disease

Mesh：

Year: 2008 PMID： 19208972 DOI： 10.1007/s12038-008-0065-0

Source DB: PubMed Journal: J Biosci ISSN： 0250-5991 Impact factor: 1.826

77 in total

1. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India.

Authors: S Singh; R Prasad; A Mohanty
Journal: Int J STD AIDS Date: 1999-07 Impact factor: 1.359

2. Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, western India.

Authors: J Nandi; V Bhawalkar; H Mody; A Elavia; P K Desai; K Banerjee
Journal: Vox Sang Date: 1994 Impact factor: 2.144

3. Prevalence of anti-HCV antibodies in central India.

Authors: S P Jaiswal; D S Chitnis; G Naik; K K Artwani; C S Pandit; P Salgia; A Sepaha
Journal: Indian J Med Res Date: 1996-08 Impact factor: 2.375

4. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Authors: S K Sarin; V Thakur; R C Guptan; S Saigal; V Malhotra; S P Thyagarajan; B C Das
Journal: J Gastroenterol Hepatol Date: 2001-06 Impact factor: 4.029

5. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.

Authors: A K Tripathi; M Khanna; N Gupta; M Chandra
Journal: J Assoc Physicians India Date: 2007-06

6. The declining risk of post-transfusion hepatitis C virus infection.

Authors: J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal: N Engl J Med Date: 1992-08-06 Impact factor: 91.245

7. Etiology of endemic viral hepatitis in urban North India.

Authors: Ravinder Kaur; Renu Gur; Nidhika Berry; P Kar
Journal: Southeast Asian J Trop Med Public Health Date: 2002-12 Impact factor: 0.267

8. Prevalence of hepatitis C virus antibodies in the general population & in selected groups of patients in Delhi.

Authors: M Irshad; S K Acharya; Y K Joshi
Journal: Indian J Med Res Date: 1995-10 Impact factor: 2.375

9. Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India.

Authors: V A Arankalle; J Jha; M O Favorov; A Chaudhari; H A Fields; K Banerjee
Journal: J Viral Hepat Date: 1995 Impact factor: 3.728

10. Genotype determination of hepatitis C virus from northern India: identification of a new subtype.

Authors: A K Panigrahi; J Roca; S K Acharya; S Jameel; S K Panda
Journal: J Med Virol Date: 1996-02 Impact factor: 2.327

36 in total

1. Prevalence of hepatitis B and C in puducherry.

Authors: Arikichenin Olithselvan; Mohamed Rela
Journal: J Clin Exp Hepatol Date: 2013-11-14

2. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.

Authors: Varun Gupta; Ashish Kumar; Praveen Sharma; Naresh Bansal; Vikas Singla; Anil Arora
Journal: J Clin Exp Hepatol Date: 2015-05-21

3. Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors?

Authors: Dakshayani Padmakar Pandit; Pradhan Pagaro M; Chaudhury Nabamita
Journal: J Clin Diagn Res Date: 2014-04-15

4. Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C.

Authors: Pn Rao; Abraham Koshy; Jacob Philip; Narayanan Premaletha; Joy Varghese; Krishnasamy Narayanasamy; Samir Mohindra; Nitin Vikas Pai; Manoj Kumar Agarwal; Ashoknanda Konar; Hasmukh B Vora
Journal: World J Hepatol Date: 2014-07-27

5. Utility of FNAC in Conjunction with Cell Block for Diagnosing Space-Occupying Lesion (SOL) of Liver with Emphasis on Differentiating Hepatocellular Carcinoma from Metastatic SOL: Analysis of 61 Cases.

Authors: Haq Sheefa; Jadhav Lata; Mubeen Basharat; Makhdoomi Rumana; Malhotra Veena
Journal: Oman Med J Date: 2016-03

Review 6. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.

Authors: Pankaj Puri; Vivek A Saraswat; Radha K Dhiman; Anil C Anand; Subrat K Acharya; Shivaram P Singh; Yogesh K Chawla; Deepak N Amarapurkar; Ajay Kumar; Anil Arora; Vinod K Dixit; Abraham Koshy; Ajit Sood; Ajay Duseja; Dharmesh Kapoor; Kaushal Madan; Anshu Srivastava; Ashish Kumar; Manav Wadhawan; Amit Goel; Abhai Verma; Gaurav Pandey; Rohan Malik; Swastik Agrawal
Journal: J Clin Exp Hepatol Date: 2016-07-02

7. Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern India.

Authors: Vinod K Dixit; Jayanta K Ghosh; Sangey C Lamtha; Pankaj Kaushik; Sundeep K Goyal; Manas K Behera; Neha Singh; Ashok K Jain
Journal: J Clin Exp Hepatol Date: 2014-06-18